Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shenzhen - Delayed Quote CNY

Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ)

Compare
7.48
+0.10
+(1.36%)
At close: April 3 at 3:04:12 PM GMT+8
Loading Chart for 002772.SZ
  • Previous Close 7.38
  • Open 7.37
  • Bid 7.48 x --
  • Ask 7.49 x --
  • Day's Range 7.33 - 7.51
  • 52 Week Range 5.52 - 8.80
  • Volume 6,540,439
  • Avg. Volume 6,914,024
  • Market Cap (intraday) 2.941B
  • Beta (5Y Monthly) 0.59
  • PE Ratio (TTM) 22.67
  • EPS (TTM) 0.33
  • Earnings Date --
  • Forward Dividend & Yield 0.30 (4.01%)
  • Ex-Dividend Date May 16, 2024
  • 1y Target Est --

Tianshui Zhongxing Bio-technology Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of edible fungi in China and internationally. The company offers flammulina velutipe mushrooms under the Xihuang, Nuwa, Xuebai, and Junfu brands; agaricus bisporus mushrooms under the Zhongxing brand; and cordyceps sinensis mushrooms, as well as packaging boxes for its products. It also engages in agriculture planting, investment management, and real estate development businesses. Tianshui Zhongxing Bio-technology Co.,Ltd. was founded in 2005 and is headquartered in Tianshui, China.

www.tszxjy.cn

5,939

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 002772.SZ

View More

Performance Overview: 002772.SZ

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002772.SZ
1.49%
SSE Composite Index (000001.SS)
0.29%

1-Year Return

002772.SZ
0.93%
SSE Composite Index (000001.SS)
8.89%

3-Year Return

002772.SZ
2.09%
SSE Composite Index (000001.SS)
1.81%

5-Year Return

002772.SZ
7.17%
SSE Composite Index (000001.SS)
20.91%

Compare To: 002772.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002772.SZ

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    2.94B

  • Enterprise Value

    3.79B

  • Trailing P/E

    22.88

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.51

  • Price/Book (mrq)

    0.89

  • Enterprise Value/Revenue

    1.96

  • Enterprise Value/EBITDA

    7.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.62%

  • Return on Assets (ttm)

    1.30%

  • Return on Equity (ttm)

    3.75%

  • Revenue (ttm)

    1.94B

  • Net Income Avi to Common (ttm)

    128.03M

  • Diluted EPS (ttm)

    0.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.52B

  • Total Debt/Equity (mrq)

    71.41%

  • Levered Free Cash Flow (ttm)

    48.7M

Research Analysis: 002772.SZ

View More

Company Insights: 002772.SZ

Research Reports: 002772.SZ

View More

People Also Watch